Rankings
▼
Calendar
GERN Q4 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$50,000
-70.8% YoY
Gross Profit
-$15M
-29484.0% margin
Operating Income
-$23M
-46532.0% margin
Net Income
-$24M
-47574.0% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
-53.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$271M
Total Liabilities
$60M
Stockholders' Equity
$211M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$50,000
$171,000
-70.8%
Gross Profit
-$15M
-$24M
+38.5%
Operating Income
-$23M
-$30M
+22.5%
Net Income
-$24M
-$29M
+18.2%
← FY 2020
All Quarters
Q1 2021 →